Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hallmarks of cancer: The CRISPR generation
Colette Moses, Benjamín Garcia-Bloj, Alan R. Harvey, et al.
European Journal of Cancer (2018) Vol. 93, pp. 10-18
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Update on gastric cancer treatments and gene therapies
Alessio Biagioni, Ileana Skalamera, Sara Peri, et al.
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 3, pp. 537-548
Closed Access | Times Cited: 164
Trends in the approval of cancer therapies by the FDA in the twenty-first century
Emma C. Scott, Andrea Baines, Yutao Gong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 625-640
Closed Access | Times Cited: 159
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 72
A detailed insight of the tumor targeting using nanocarrier drug delivery system
Sibgha Batool, Saba Sohail, Fakhar ud Din, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 60
Genotoxicity assessment of carbon-based nanomaterials; Have their unique physicochemical properties made them double-edged swords?
Hadi Samadian, Mohammad Saeid Salami, Mehdi Jaymand, et al.
Mutation Research/Reviews in Mutation Research (2020) Vol. 783, pp. 108296-108296
Closed Access | Times Cited: 104
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
Colette Moses, Fiona Nugent, Charlene Waryah, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 14, pp. 287-300
Open Access | Times Cited: 95
<p>Resistance and Overcoming Resistance in Breast Cancer</p>
Andrea Luque-Bolivar, Erika Pérez-Mora, Victoria Eugenia Villegas, et al.
Breast Cancer Targets and Therapy (2020) Vol. Volume 12, pp. 211-229
Open Access | Times Cited: 83
Design and synthesis of phenylthiophosphoryl dichloride derivatives and evaluation of their antitumour and anti-inflammatory activities
Chunyun Xu, Na Yang, Hsiao‐Wei Yu, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access | Times Cited: 1
Wet chemical mediated hematite α-Fe2O3 nanoparticles synthesis: Preparation, characterization and anticancer activity against human metastatic ovarian cancer
Vaikundamoorthy Ramalingam, Harshavardhan Mohan, Subbaraj Dinesh Kumar, et al.
Journal of Alloys and Compounds (2020) Vol. 834, pp. 155118-155118
Closed Access | Times Cited: 59
Is Viral Vector Gene Delivery More Effective Using Biomaterials?
Yi Wang, Kiara F. Bruggeman, Stephanie Franks, et al.
Advanced Healthcare Materials (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 55
Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment
Shahin Aghamiri, Sam Talaei, Afshin Abdi Ghavidel, et al.
Journal of Drug Delivery Science and Technology (2020) Vol. 56, pp. 101533-101533
Closed Access | Times Cited: 52
Flavor components, precursors, formation mechanisms, production and characterization methods: garlic, onion, and chili pepper flavors
Jieying Li, Younas Dadmohammadi, Alireza Abbaspourrad
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 30, pp. 8265-8287
Closed Access | Times Cited: 43
Targeting Cancer with CRISPR/Cas9-Based Therapy
Katarzyna Balon, Adam Sheriff, J. Jackow, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 573-573
Open Access | Times Cited: 38
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
Sihong Chen, Yingxi Zhao, Shougeng Liu, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100821-100821
Closed Access | Times Cited: 34
Plant-derived exosome-like nanoparticles for microRNA delivery in cancer treatment
Chun Yi, Linzhu Lu, Zhaosheng Li, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 7
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
Małgorzata Bajor, Agata O. Zych, Agnieszka Graczyk‐Jarzynka, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 7, pp. 873-884
Open Access | Times Cited: 55
CRISPR: History and perspectives to the future
Zuzana Kozovská, S. Rajcaniova, P. Munteanu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111917-111917
Open Access | Times Cited: 41
Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase
Farah Anjum, Taj Mohammad, Abdulraheem Ali Almalki, et al.
OMICS A Journal of Integrative Biology (2021) Vol. 25, Iss. 9, pp. 580-590
Closed Access | Times Cited: 37
Reviewing cancer’s biology: an eclectic approach
Ibrahim KARIDIO DIORI, Şenay Hamarat Şanlıer
Journal of the Egyptian National Cancer Institute (2021) Vol. 33, Iss. 1
Open Access | Times Cited: 36
Correlation of serum NLR, PLR and HALP with efficacy of neoadjuvant chemotherapy and prognosis of triple-negative breast cancer.
Caiyu Lou, Fenyuan Jin, Qiang Zhao, et al.
PubMed (2022) Vol. 14, Iss. 5, pp. 3240-3246
Closed Access | Times Cited: 27
Recent developments in selenium-containing polymeric micelles: prospective stimuli, drug-release behaviors, and intrinsic anticancer activity
Yihenew Simegniew Birhan, Hsieh‐Chih Tsai
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 34, pp. 6770-6801
Closed Access | Times Cited: 25
PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities
Xiang Jin, Kai Wang, Ni Tang
Genes & Diseases (2022) Vol. 10, Iss. 1, pp. 101-112
Open Access | Times Cited: 19
Investigating the interaction between calcium signaling and ferroptosis for novel cancer treatment
Haohao Yan, Ying‐Chuang Zhang, Yuqing Niu, et al.
Phytomedicine (2025) Vol. 137, pp. 156377-156377
Closed Access
The applications of CRISPR systems in cancer detection
Xinmeng Li
Theoretical and Natural Science (2025) Vol. 82, Iss. 1, pp. 45-51
Closed Access
Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy
Farzana Sharif, Azhar Rasul, Asma Ashraf, et al.
IUBMB Life (2019) Vol. 71, Iss. 10, pp. 1418-1427
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top